ES2156602T3 - Expresion de albumina en levaduras. - Google Patents

Expresion de albumina en levaduras.

Info

Publication number
ES2156602T3
ES2156602T3 ES95921063T ES95921063T ES2156602T3 ES 2156602 T3 ES2156602 T3 ES 2156602T3 ES 95921063 T ES95921063 T ES 95921063T ES 95921063 T ES95921063 T ES 95921063T ES 2156602 T3 ES2156602 T3 ES 2156602T3
Authority
ES
Spain
Prior art keywords
pct
albumina
leaves
expression
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95921063T
Other languages
English (en)
Inventor
Patricia Carol Wood
Alan Victor Quirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albumedix Ltd
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of ES2156602T3 publication Critical patent/ES2156602T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA REDUCCION (PREFERIBLEMENTE LA ELIMINACION) DE LA PROTEINA HSP150, EN UNA LEVADURA UTILIZADA PARA PRODUCIR PROTEINAS FORANEAS DESEADAS, ESPECIALMENTE ALBUMINA HUMANA, FACILITA LA PURIFICACION POSTERIOR DE DICHA PROTEINA.
ES95921063T 1994-06-07 1995-06-07 Expresion de albumina en levaduras. Expired - Lifetime ES2156602T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9411356A GB9411356D0 (en) 1994-06-07 1994-06-07 Yeast strains

Publications (1)

Publication Number Publication Date
ES2156602T3 true ES2156602T3 (es) 2001-07-01

Family

ID=10756304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95921063T Expired - Lifetime ES2156602T3 (es) 1994-06-07 1995-06-07 Expresion de albumina en levaduras.

Country Status (14)

Country Link
US (1) US5783423A (es)
EP (1) EP0764209B1 (es)
JP (1) JP3667339B2 (es)
KR (1) KR100380532B1 (es)
AT (1) ATE198624T1 (es)
AU (1) AU698319B2 (es)
CA (1) CA2190373C (es)
DE (1) DE69519856T2 (es)
DK (1) DK0764209T3 (es)
ES (1) ES2156602T3 (es)
GB (2) GB9411356D0 (es)
GR (1) GR3035568T3 (es)
PT (1) PT764209E (es)
WO (1) WO1995033833A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6274305B1 (en) 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6258559B1 (en) * 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
WO2000071738A1 (en) 1999-05-21 2000-11-30 Cargill Dow Llc Methods and materials for the synthesis of organic products
EP2213743A1 (en) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albumin fusion proteins
EP1363992A1 (en) * 2001-02-26 2003-11-26 DSM IP Assets B.V. Method for increasing the intracellular glutamate concentration in yeast
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
WO2002101038A1 (fr) 2001-05-29 2002-12-19 Asahi Glass Company, Limited Procede de construction d'un hote et procede de production d'une proteine etrangere
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2003066824A2 (en) 2002-02-07 2003-08-14 Aventis Behring Gmbh Albumin-fused kunitz domain peptides
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
GB0224082D0 (en) * 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
WO2006067511A1 (en) 2004-12-23 2006-06-29 Novozymes Delta Limited Gene expression technique
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
CN101511868B (zh) 2006-07-24 2013-03-06 比奥雷克西斯制药公司 毒蜥外泌肽融合蛋白
US9505823B2 (en) * 2006-08-07 2016-11-29 TEV A Biopharmaceuticals USA, Inc. Albumin-insulin fusion proteins
WO2009019314A1 (en) 2007-08-08 2009-02-12 Novozymes A/S Transferrin variants and conjugates
JP2012516878A (ja) 2009-02-06 2012-07-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 精製プロセス
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
EP2964666B1 (en) * 2013-03-06 2020-11-18 GlaxoSmithKline LLC Host cells and methods of use
EP3030710B1 (en) 2013-08-09 2017-10-11 Novozymes A/S Reducing content of hexenuronic acids in cellulosic pulp
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
JP2024500994A (ja) 2020-12-28 2024-01-10 デボル，インコーポレイテッド タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料

Also Published As

Publication number Publication date
CA2190373A1 (en) 1995-12-14
ATE198624T1 (de) 2001-01-15
JP3667339B2 (ja) 2005-07-06
WO1995033833A1 (en) 1995-12-14
AU698319B2 (en) 1998-10-29
JPH10501123A (ja) 1998-02-03
EP0764209A1 (en) 1997-03-26
DK0764209T3 (da) 2001-03-19
AU2626295A (en) 1996-01-04
CA2190373C (en) 2003-01-07
US5783423A (en) 1998-07-21
KR100380532B1 (ko) 2004-03-24
EP0764209B1 (en) 2001-01-10
PT764209E (pt) 2001-05-31
GB9411356D0 (en) 1994-07-27
GB2302329B (en) 1998-04-29
DE69519856D1 (de) 2001-02-15
GR3035568T3 (en) 2001-06-29
GB9622229D0 (en) 1996-12-18
GB2302329A (en) 1997-01-15
DE69519856T2 (de) 2001-07-19

Similar Documents

Publication Publication Date Title
ES2156602T3 (es) Expresion de albumina en levaduras.
DE59507920D1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
NO963239L (no) Klorpyrimid-mellomprodukter
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
DE69131961D1 (de) Für die reinigung bestimmte klonierung von peptiden
PL312712A1 (en) High level expression, purification and repeated creasing of group b(porynowe?) proteins of outer membrane of neisseria meningitidis
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
PT749478E (pt) Estirpes de levedura e albuminas modificadas
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
MX9700244A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye.
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
SE9400524D0 (sv) Energipreparat
MX9605854A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo contiene.
AU637589B2 (en) Ancrod proteins, their production and use
DE69323191D1 (de) Wasserlösliche retinoide
ATE315583T1 (de) Analoge des thymosin alpha 1
ATE235260T1 (de) Verfahren zum herstellen von nebenwirkungsfreien konstrastmitteln bei ultrafiltration
ATA166890A (de) Rekombinantes dna-molekül für allergene des erlenpollens, damit hergestellte proteine bzw. polypeptide, sowie deren anwendung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 764209

Country of ref document: ES